[HTML][HTML] The evolving role of investigative toxicology in the pharmaceutical industry

F Pognan, M Beilmann, H Boonen, A Czich… - Nature reviews drug …, 2023 - nature.com
For decades, preclinical toxicology was essentially a descriptive discipline in which
treatment-related effects were carefully reported and used as a basis to calculate safety …

Multiorgan-on-a-chip: a systemic approach to model and decipher inter-organ communication

N Picollet-D'hahan, A Zuchowska, I Lemeunier… - Trends in …, 2021 - cell.com
Multiorgan-on-a-chip (multi-OoC) platforms have great potential to redefine the way in which
human health research is conducted. After briefly reviewing the need for comprehensive …

Bioprinting 3D microfibrous scaffolds for engineering endothelialized myocardium and heart-on-a-chip

YS Zhang, A Arneri, S Bersini, SR Shin, K Zhu… - Biomaterials, 2016 - Elsevier
Engineering cardiac tissues and organ models remains a great challenge due to the
hierarchical structure of the native myocardium. The need of integrating blood vessels brings …

Tissue–electronics interfaces: from implantable devices to engineered tissues

R Feiner, T Dvir - Nature Reviews Materials, 2017 - nature.com
Biomedical electronic devices are interfaced with the human body to extract precise medical
data and to interfere with tissue function by providing electrical stimuli. In this Review, we …

Current status of bioinks for micro-extrusion-based 3D bioprinting

A Panwar, LP Tan - Molecules, 2016 - mdpi.com
Recent developments in 3D printing technologies and design have been nothing short of
spectacular. Parallel to this, development of bioinks has also emerged as an active research …

Decellularized matrices in regenerative medicine

DA Taylor, LC Sampaio, Z Ferdous, AS Gobin, LJ Taite - Acta biomaterialia, 2018 - Elsevier
Of all biologic matrices, decellularized extracellular matrix (dECM) has emerged as a
promising tool used either alone or when combined with other biologics in the fields of tissue …

3D bioprinting of functional tissue models for personalized drug screening and in vitro disease modeling

X Ma, J Liu, W Zhu, M Tang, N Lawrence, C Yu… - Advanced drug delivery …, 2018 - Elsevier
Abstract 3D bioprinting is emerging as a promising technology for fabricating complex tissue
constructs with tailored biological components and mechanical properties. Recent advances …

Organ‐on‐a‐chip platforms: a convergence of advanced materials, cells, and microscale technologies

S Ahadian, R Civitarese, D Bannerman… - Advanced …, 2018 - Wiley Online Library
Significant advances in biomaterials, stem cell biology, and microscale technologies have
enabled the fabrication of biologically relevant tissues and organs. Such tissues and organs …

Advances in engineering human tissue models

CM Moysidou, C Barberio, RM Owens - Frontiers in bioengineering …, 2021 - frontiersin.org
Research in cell biology greatly relies on cell-based in vitro assays and models that facilitate
the investigation and understanding of specific biological events and processes under …

[HTML][HTML] Cardiovascular disease models: a game changing paradigm in drug discovery and screening

H Savoji, MH Mohammadi, N Rafatian, MK Toroghi… - Biomaterials, 2019 - Elsevier
Cardiovascular disease is the leading cause of death worldwide. Although investment in
drug discovery and development has been sky-rocketing, the number of approved drugs has …